Sponsored · Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5024,287.650.32%H 24,360.1 · L 24,226.95|Sensex77,728.160.36%H 77,928.68 · L 77,453.75|Bank Nifty57,497.80.01%H 57,757.25 · L 57,119.6|USD / INR₹95.590.19%H ₹95.61 · L ₹95.42|Gold Intl (10g)₹1,37,166.770.58%H ₹1,37,477.18 · L ₹1,35,912.84|Silver Intl (1kg)₹2,02,149.721.02%H ₹2,04,055.2 · L ₹1,99,306.87|Crude WTI₹7,898.770.28%H ₹7,956.12 · L ₹7,790.75|Bitcoin₹60,78,5800.9%H ₹61,06,004.47 · L ₹60,51,155.53|Ethereum₹1,81,6891.06%H ₹1,82,653.54 · L ₹1,80,724.46|Nifty 5024,287.650.32%H 24,360.1 · L 24,226.95|Sensex77,728.160.36%H 77,928.68 · L 77,453.75|Bank Nifty57,497.80.01%H 57,757.25 · L 57,119.6|USD / INR₹95.590.19%H ₹95.61 · L ₹95.42|Gold Intl (10g)₹1,37,166.770.58%H ₹1,37,477.18 · L ₹1,35,912.84|Silver Intl (1kg)₹2,02,149.721.02%H ₹2,04,055.2 · L ₹1,99,306.87|Crude WTI₹7,898.770.28%H ₹7,956.12 · L ₹7,790.75|Bitcoin₹60,78,5800.9%H ₹61,06,004.47 · L ₹60,51,155.53|Ethereum₹1,81,6891.06%H ₹1,82,653.54 · L ₹1,80,724.46|
0%
Investment Ideas

Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth

Arth Vani DeskPublished: 1 min read
Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth

Source: Mint Markets

Arth Insight · What this means for your wallet

Immediate action
Check your portfolio's sector allocation to ensure you aren't over-exposed to high-valuation pharma stocks.
  • A 350% return turns a ₹1 lakh investment into ₹4.5 lakh, highlighting the wealth-building power of long-term equity holding.
  • The 120% profit jump suggests strong business health, which often leads to higher dividends or further stock price appreciation.
  • Rapid surges can lead to high 'Price-to-Earnings' ratios, meaning new investors might pay a premium price for future growth.

Wealth-Impact Simulator

See what a one-time investment could grow to.

Amount invested₹1,00,000
Holding period10 yrs
Expected return (p.a.)12%
Future value
₹3,10,585
Potential gain
₹2,10,585

Indicative estimate for education only — not investment advice.

Explore investments
Remind Me Radar
Remind me when this story updates
Recommended for you
Discover financial products for you
Explore
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Sakar Healthcare's share price saw a significant jump, trading at ₹817.45 today, following a 120% year-on-year rise in net profit for Q1 FY27. The stock has delivered a remarkable 350% return over the past five years.

Key Highlights
  • Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
  • The stock has delivered a 350% return over the last five years.
  • The company's strong financial performance has led to significant shareholder value creation.
Key Takeaways
  • Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
  • The stock has delivered a 350% return over the last five years.
  • The company's strong financial performance has led to significant shareholder value creation.

Sakar Healthcare's stock opened at ₹817.45 today, up from its previous close of ₹802.20, reaching an intraday high of ₹833.90 on July 27. This surge follows the company's impressive financial results, which reported a 120% year-on-year increase in net profit for the first quarter of the fiscal year 2027 (Q1 FY27).

Over the last five years, Sakar Healthcare has demonstrated exceptional growth, with its share price rallying by approximately 350%. This sustained performance indicates strong investor confidence and robust operational execution by the company.

The company's financial performance in Q1 FY27 highlights its ability to significantly boost profitability. While specific figures for the net profit amount were not provided in the source material, the percentage increase suggests a substantial improvement in earnings.

Investors in Sakar Healthcare have benefited from this upward trend. The stock's consistent rally over half a decade points to its status as a multibagger, rewarding early investors with substantial returns. The recent profit jump is likely to further fuel interest in the stock.

This article is for informational purposes only and does not constitute investment advice.

Community Pulse · This story

How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.

Bullish 50%50% Bearish
Be the first to call it
Did this advice help you?
Recommended for you
Products related to this story — compare & act
Smart picks
HDFC NIFTY Next 50 Index Fund
HDFC Mutual Fund · Index
19.5%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Nippon India Small Cap Fund Growth Plan
Nippon India Mutual Fund · Small Cap
17.8%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
14.5%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
14.5%
3Y CAGR

Mutual fund data is sourced from AMFI and shown for information only — funds are subject to market risks. Read all scheme-related documents carefully. Some listings may be sponsored. Not investment advice.

Frequently Asked Questions

What is Sakar Healthcare's recent stock performance?

Sakar Healthcare's stock opened at ₹817.45 today, up from ₹802.20, and reached an intraday high of ₹833.90 on July 27. It has rallied 350% in five years.

Why has Sakar Healthcare's stock seen a surge?

The stock surge is attributed to the company reporting a 120% year-on-year rise in net profit for Q1 FY27.

What does a 'multibagger' stock mean?

A multibagger stock is one that provides returns of more than 100%, significantly multiplying the initial investment.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

Netflix Stock: Global Analysis Points to Over 70% Upside Potential
Investment Ideas

Netflix Stock: Global Analysis Points to Over 70% Upside Potential

A global analysis, highlighted by Yahoo Finance, suggests streaming giant Netflix (NFLX) stock is currently undervalued and could see more than 70% upside. Specific details and the full rationale for this projection were not available in the provided source material.

13h ago·1 min readListen
Unlocking Home Equity: Should You Invest in Rental Property in India?
Breaking
Investment Ideas

Unlocking Home Equity: Should You Invest in Rental Property in India?

Many Indian homeowners consider using their home equity to fund new investments, with rental property being a popular option. This move can offer potential income and appreciation but comes with significant risks that require careful financial planning and market research.

4d ago·3 min readListen
Best Travel Credit Cards in India 2024: Top Picks After Reward Devaluations
Breaking
Investment Ideas

Best Travel Credit Cards in India 2024: Top Picks After Reward Devaluations

As major banks slash reward points and lounge access benefits, a new set of travel credit cards has emerged as value leaders. This year's rankings highlight cards that offer the best return on travel spends despite industry-wide devaluations.

8d ago·2 min readListen
Citi Raises Microsoft Stock Target to ₹50,100 After Strong Azure Performance
Investment Ideas

Citi Raises Microsoft Stock Target to ₹50,100 After Strong Azure Performance

Financial giant Citi has increased its target price for Microsoft shares to $600, which translates to approximately ₹50,100, following a stronger-than-expected earnings performance from the tech company's cloud computing division, Azure. This upgrade reflects strong analyst confidence in Microsoft's growth trajectory, particularly in its lucrative cloud services segment.

9d ago·2 min readListen

Daily 3-minute money update on WhatsApp

Join 50,000+ investors — free.